Big Pharma Watch: Drug Maker Hit With $15 Million Penalty for Illegal Price Hike Scheme
Sep 10, 2019
In case you missed it, a recent article in HealthLeaders details how brand… Read More
© 2024 CSRXP- All Rights Reserved
Updates
Going Boldly To The Bottom: Poll Finds Opinion Of Big Pharma Hits Record Low
Sep 3, 2019
Americans Have Negative View of Drug Makers by Two-to-One Margin… Read More
What They Are Saying: Americans Urge Action to Lower Drug Prices, Hold Big Pharma Accountable
Aug 29, 2019
Voices From Around the Country Call for Congress to Pass Senate Finance… Read More
Big Pharma Watch: How Drug Makers Use Charities to Pad Their Bottom Line
Aug 29, 2019
In case you missed it, a recent article in The Economist digs into the inner… Read More
Big Pharma Watch: Drug Makers Tone Deaf on Crisis of Affordability
Aug 22, 2019
BIO CEO Says Prescription Drugs Are Not Too Expensive If you needed any more… Read More
CSRxP Commends Administration for Commitment to DTC Advertising Rule
Aug 21, 2019
Applauds HHS For Appealing Ruling Against List Price Transparency Measure… Read More
Second Opinion: GAO Undermines Common Refrain in Big Pharma’s Blame Game
Aug 16, 2019
Analysis Finds PBMs Pass On Over 99 Percent of Rebates, Used to Keep Premiums… Read More
Q2 Earnings: Big Pharma Keeps Living the Good Life While Evading Accountability
Jul 31, 2019
Q2 Earnings: Big Pharma Keeps Living the Good Life While Evading… Read More
Big Pharma Earnings Watch: Amgen, Eli Lilly, Merck and Pfizer
Jul 31, 2019
Four More Rx Giants Complete the Sweep, Beat Q2 Earnings Forecasts After… Read More
Big Pharma Earnings Watch: AbbVie and Sanofi
Jul 30, 2019
Brand Name Drug Makers Continue to Surpass Q2 Forecasts After Hiking Prices… Read More
Big Pharma Earnings Watch: Bristol-Myers Squibb, AstraZeneca, Roche
Jul 29, 2019
Three More Drug Makers Top Earnings Expectations in Q2 Today three more… Read More
CSRxP: Senate Finance Takes Positive Steps to Hold Big Pharma Accountable, Lower Drug Prices
Jul 25, 2019
Commends Bipartisan Collaboration on Several Market-Based Solutions… Read More